MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Vitamin D in early Parkinson’s disease

    I.M. Sleeman, T. Aspray, S. Coleman, G. Duncan, T.K. Khoo, I. Schoenmakers, L. Rochester, D.J. Burn, A.J. Yarnall (Newcastle, United Kingdom)

    Objective: To determine serum 25-hydroxy vitamin D (25OHD) concentration at diagnosis and 18 months in incident Parkinson's disease (PD) compared to controls and to investigate…
  • 2016 International Congress

    Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

    L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)

    Objective: Swallow and speech disturbances are common in patients with atypical parkinsonism. The emergence of swallowing problems, or dysphagia, is associated with increased morbidity and…
  • 2016 International Congress

    Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

    Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

    Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…
  • 2016 International Congress

    MicroRNA as diagnostic biomarkers in Parkinson’s disease and multiple system atrophy

    C.C. Starhof, K. Winge, N. Heegaard, A.M. Hejl (København, Denmark)

    Objective: In this study, we aimed to 1) perform miRNA profiling in CSF and subsequent 2) validate biomarker potential of differentially expressed miRs in (different)…
  • 2016 International Congress

    Increased monosaccharide intake in patients with Parkinson’s disease

    E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)

    Objective: To verify the clinical observation that patients with Parkinson's disease (PD) have a higher consumption of monosaccharides. Background: Patients with PD frequently report an…
  • 2016 International Congress

    Chin EMG variance and dream-enactment behavior during polysomnography in Parkinson’s disease

    Y. Shen, K.P. Xiong, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

    Objective: The aim of this study was to exam relationships between REM sleep muscle atonia (RSWA), dream-enactment behavior(DEB) and clinical characteristics in Parkinson's disease (PD)…
  • 2016 International Congress

    Evolution of mild Parkinsonian signs in a longitudinal population-based cohort

    J. Hampf, S. Tunc, J. Graf, K. Hückelheim, E.J. Vollstedt, B. Staemmler, C. Klein, M. Kasten (Luebeck, Germany)

    Objective: To investigate evolution of mild Parkinsonian signs (MPS) in an ongoing longitudinal study on Parkinson's disease (PD). Background: Mild motor impairmant may progress to…
  • 2016 International Congress

    Parasacral effects of electrical stimulation on lower urinary tract symptoms and constipation in patients with Parkinson’s disease: Preliminary data

    I.V. Brandi, L.F. Silva, A.M. Lanzarini, A.F.A. Musengante (Salvador, Brazil)

    Objective: To evaluate the effectiveness of parasacral electrostimulation in symptoms of lower urinary tract and constipation, besides the urodynamic parameters in patients with Parkinson's disease.…
  • 2016 International Congress

    Prevalence of Parkinson’s disease in Ukraine

    Y.O. Trufanov, N.K. Svyrydova, A.I. Galusha, G.M. Chupryna, O.V. Popov, M.V. Nechkalyuk (Kyiv, Ukraine)

    Objective: To compare the prevalence of Parkinson's disease (PD) in Ukraine in 2010 and 2014; to compare the prevalence of PD in Ukraine with other…
  • 2016 International Congress

    Genetic risk of Parkinson’s disease in the general population

    S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

    Objective: We investigated whether a genetic risk score for Parkinson's disease (PD) is associated with the risk of incident PD, and whether the risk score…
  • « Previous Page
  • 1
  • …
  • 329
  • 330
  • 331
  • 332
  • 333
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley